Glaucoma is one of the leading causes of blindness: 70 million people worldwide are affected.
Glaucoma is a progressive disease of the eye that causes damage to the optic nerve, which is the pathway that carries the image we see to the brain. Development over time can cause visual impairment and sometimes complete blindness.
Glaucoma can affect anyone. Certain factors increase the risk like diabetes and family history.
Early detection is intended to help in the prevention of vision loss as treatment can begin before potentially sight threatening damage is caused to the optic nerve. People are completely free of symptoms in the early stages of the disease and feel deceptively healthy. This is why the gradual progression of Glaucoma is has, until today, not been noticed until a partial loss of vision has already occurred.
We know that if Glaucoma is caught as early as possible then there is a much greater chance of limiting this damage to prevent loss of vision. Until recently, by the time Glaucoma was detected during a routine eye examination some damage would have already occurred.
We have therefore invested in a new instrument called the Optopol RevoFC. This instrument reveals the early signs of Glaucoma, years before any noticeable symptoms appear and years before the traditionally examinations that have been employed in the past.
There is no guaranteed protection against Glaucoma. However, early detection may help prevent an individual suffering from the severe consequences of the disease. Scanning with our Optopol RevoFC system is done as standard. This combines industry leading OCT imaging with a confocal scanning laser ophthalmoscope (SLO) in one highly advanced instrument and allows the diagnosis and tracking of changes in the most complex retinal diseases and their treatments.
With our state of the art Optopol RevoFC scanner, your macular and optic nerve health can now be also monitored. The exam is quick and painless, but will occasionally require dilation drops.